TY  - CHAP
M1  - Book, Section
TI  - Tumors of the Liver and Biliary Tree
A1  - Llovet, Josep M.
A2  - Jameson, J. Larry
A2  - Fauci, Anthony S.
A2  - Kasper, Dennis L.
A2  - Hauser, Stephen L.
A2  - Longo, Dan L.
A2  - Loscalzo, Joseph
Y1  - 2018
N1  - 
T2  - Harrison's Principles of Internal Medicine, 20e
AB  - The  burden  of  cancer  is  increasing  worldwide.  Lung,  breast,  and  colorectal  cancers  are  the  most  commonly  diagnosed  while  lung  and  liver  cancers  are  the  most  common  causes  of  cancer  death.  Liver  cancer  is  the  sixth  most  common  cancer  worldwide,  the  second  leading  cause  of  cancer-related  deaths  and  one  of  the  few  neoplasms  whose  incidence  and  mortality  rates  have  been  steadily  increasing.  Liver  cancer  comprises  a  heterogeneous  group  of  malignant  tumors  with  different  histologic  features  and  unfavorable  prognosis  that  range  from  hepatocellular  carcinoma  (HCC;  85–90%  cases),  intrahepatic  cholangiocarcinoma  (iCCA;  10%),  and  other  malignancies  accounting  for  <1%  of  tumors,  such  as  fibrolamellar  HCC,  mixed  HCC-iCCA,  epithelioid  hemangiothelioma,  and  the  pediatric  cancer  hepatoblastoma.  The  burden  of  liver  cancer  is  increasing  globally  in  almost  all  countries,  and  it  is  estimated  to  reach  one  million  cases  by  2030.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1156514128
ER  -